POINT Biopharma Global Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q2 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
POINT Biopharma Global Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2020 to Q1 2023.
  • POINT Biopharma Global Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$22.4M, a 113% decline year-over-year.
  • POINT Biopharma Global Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $184M.
  • POINT Biopharma Global Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$44.7M, a 438% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$22.4M -$11.9M -113% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 -$10.5M +$476K +4.34% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 -$11M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q2 2020 -$18K* Apr 15, 2020 Jun 30, 2020 10-Q 2020-08-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.